QURE - Uniqure NV logo

QURE

Uniqure NV

uniQure N.V. develops gene therapies for rare diseases, focusing on hemophilia B, Huntington's disease, and epilepsy. Its products include HEMGENIX for hemophilia B and candidates AMT-130, AMT-260, AMT-162, and AMT-191 in clinical trials.

โš•๏ธ Healthcare NASDAQ Listed 2007 $ USD
$1,000 invested 10 years ago โ†’$5,260today

Score Overview

1 Year
Score
Net Growth-26.76%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth15.99%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score2.6
Net Growth-176.52%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-96.44%
Rev Trend40%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-243.73%
Net Trend30%
Net Income Consistency
Rev Growth-25.60%
Rev Trend40%
Revenue Consistency
All Time
Scoreโ€”
Net Growthโ€”
Net Trend33%
Net Income Consistency
Rev Growthโ€”
Rev Trend54%
Revenue Consistency

See the full market ranking โ†’

Uniqure NV fundamental performance

Between 2020 and 2025, revenue declined from $ 37M to $ 16M and net income went from -$ 125M to -$ 198M. Revenue increased in 2 of those 5 years; net income in 2.

Between 2015 and 2025, revenue grew from $ 10M to $ 16M and net income went from -$ 78M to -$ 198M. Revenue increased in 4 of those 10 years; net income in 3.

Uniqure NV currently holds a 5-year HDB Score of 2.6 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 45.13โ€”
1 Year2025-08-12
$ 14.30215.59%
5 Years2021-08-12
$ 29.3054.03%
10 Years2016-08-12
$ 8.58425.99%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 18M-$ 252M$ 810M
2025$ 16M-$ 198M$ 622M
2024$ 27M-$ 239M$ 367M
2023$ 15M-$ 308M$ 617M
2022$ 106M-$ 126M$ 352M
2021$ 524M$ 329M$ 556M
2020$ 37M-$ 125M$ 244M
2019$ 7M-$ 124M$ 377M
2018$ 11M-$ 83M$ 234M
2017$ 13M-$ 80M$ 159M
2016$ 25M-$ 73M$ 132M
2015$ 10M-$ 78M$ 222M
2014$ 5M-$ 45M$ 64M
2013$ 4M-$ 37M$ 32M
2012-$ 19M$ 347.82K
2011-$ 22M$ 1M
2010$ 23M

Explore beyond QURE

You're looking at Uniqure NV. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies